用于儿童脏保护的SGLT2抑制剂:扩大超越内分泌学的视野
Costanza Pucci1,2, Davide Silvio Marazza3, Evgenia Preka4,5
1University of Milan, Milan, Italy. costanza.pucci@unimi.it.
Pediatric nephrology (Berlin, Germany)
|July 7, 2025
概括
-葡萄糖共运输体2抑制剂 (SGLT2i) 显示出保护儿童脏的潜力,可能为目前的治疗提供替代方案. 需要进一步的研究来确认它们在儿科慢性病 (CKD) 中的疗效和安全性.
科学领域:
- 儿科脏病学 儿科脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 儿童目前的脏保护依赖于ACE抑制剂 (ACEi) 和ARBs,但它们有局限性.
- 起初用于糖尿病的-葡萄糖共运输体2抑制剂 (SGLT2i) 在患有慢性病 (CKD) 的成年人中显示出对的益处.
- 儿科CKD的病理生理学,通常与脏和泌尿道 (CAKUT) 的先天性异常有关,与成人CKD不同.
研究的目的:
- 审查SGLT2抑制剂在治疗儿科慢性病 (CKD) 的潜力.
- 探索SGLT2i在儿科病中的机制,临床证据和未来方向.
- 评估SGLT2i作为超越儿童糖尿病管理的新型治疗策略.
主要方法:
- 对成人和儿科CKD中SGLT2抑制剂的现有文献的综述.
- 对儿科患者群体初步病例系列和小型临床试验的分析.
- 讨论正在进行的大规模试验,例如双重保护阿尔波特试验.
主要成果:
- 预先的研究表明,SGLT2i可以减少高过,蛋白尿和慢慢的CKD进展在儿童中,与RAS阻断剂一起.
- 最近的儿科研究显示出有希望的结果,表明对功能保护的潜在益处.
- 目前正在进行的试验至关重要,以确认SGLT2i在儿科CKD中的疗效和安全性.
结论:
- SGLT2抑制剂代表了儿科CKD的潜在新型治疗策略,提供了超越其抗糖尿病作用的好处.
- 仔细监测诸如euglycemic ketoacidosis (EuDKA) 和矿物质不平衡等不良影响至关重要.
- 需要进行更大规模的受控研究,以确定SGLT2i在患有CKD的儿童中的有效性和安全性.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
Acute Kidney Injury V: Interprofessional Care
48
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
48
Antihypertensive Drugs: Potassium-Sparing Diuretics
777
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
777
Renal Drug Excretion: Overview
288
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
288
Kidney Transplant I: Introduction
64
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
64


